Catalog |
name |
Description |
price |
R-M2-9866 |
CHOL-PEG-THRPPMWSPVWP-NH2 |
CHOL-PEG-THRPPMWSPVWP-NH2is a peptide conjugate.
Applications:
Targeted liposomal drug delivery (smallmolecules, siRNA, peptides).
Theranostic nanocarriers with imaging agent attachment.
Surface functionalization of liposomes, polymersomes, or hybrid nanoparticles. |
price> |
R-M2-9868 |
LPGA8K-PEG2K-CTHRSSWC |
LPGA8K-PEG2K-CTHRSSWC is a peptide conjugate.This structure combines biocompatibility, water solubility, and peptide-mediated active targeting, making it suitable for drug delivery and nanomedicine applications.Linear poly(L-glutamic acid) is a biodegradable, water-soluble polypeptide composed of repeating L-glutamic acid residues linked through α-peptide bonds. The polymer backbone provides multiple carboxyl groups that can be used for drug conjugation, crosslinking, or surface modification.
Applications:
Targeted drug delivery (chemotherapeutics, siRNA, imaging agents).
Nanoparticle surface functionalization for active tumor targeting.
Development of stimuli-responsive polymeric carriers in cancer therapy. |
price> |
R-M1-8246 |
c(RGDfK)-PEG2-MAL |
C(RGDfK)-PEG2-MAL is a cyclic peptide modified heterobifunctional peg reagent. |
price> |
R-M1-8247 |
mPEG2000-GPLGIAGQC |
MPEG2000-GPLGIAGQC is a single functionalized peg reagent modified with sequence peptides. |
price> |
R-M2-9883 |
DMG-PEG-CTHRSSWC |
DMG-PEG-CTHRSSWC is typically applied in the development of peptide-functionalized nanocarriers for selective drug delivery and therapeutic applications. |
price> |
R-M2-9884 |
DMG-PEG-Angiopep-2 |
DMG-PEG-Angiopep-2/DMG-PEG-Ang-2 is a type of nanoparticle system designed for brain-targeted drug delivery, specifically for conditions like brain tumors or neurodegenerative diseases. DMG-PEG is a lipid-based component that forms the nanoparticle, while Angiopep-2 is a peptide that acts as a "key" to unlock the blood-brain barrier (BBB) by binding to the LRP1 receptor. This allows the nanoparticle to carry therapeutic agents directly into the brain, increasing their concentration at the target site and improving treatment efficacy. |
price> |
R-M2-9886 |
THRPPMWSPVWP-PEG-Polyglutamic acid |
THRPPMWSPVWP-PEG-Polyglutamic acid is a peptide conjugate.Polyglutamic acid is a biodegradable, water-soluble polypeptide composed of repeating units of glutamic acid linked through amide bonds. It can exist in α-PGA (α-carboxyl linked) or γ-PGA (γ-carboxyl linked) forms.
THRPPMWSPVWP-PEG-Polyglutamic acid is typically used in the design of peptide-functionalized nanocarriers for targeted cancer therapy and controlled drug release. |
price> |
R-M2-9887 |
CTHRSSWC-PEG-Propargyl |
CTHRSSWC-PEG-Propargyl is commonly used for biological coupling, drug delivery, or nanomaterial modification. |
price> |
R-M2-9888 |
CHOL-PEG-CTHRSSWC |
CHOL-PEG-CTHRSWC/Cholesterol-PEG-CTHRSSWC is a multifunctional nanomaterial primarily used for tumor targeted therapy and drug delivery systems.
Application areas:
Targeted drug delivery: Loading chemotherapy drugs (such as paclitaxel) or gene therapy molecules (siRNA) to increase tumor tissue enrichment.
Immunotherapy: Combining immune modulators (such as PD-1 antibodies) to enhance anti-tumor immune response.
Nanoparticle modification: Stabilize gold nanoparticles (AuNPs) through PEG cholesterol structure for biosensing or imaging purposes. |
price> |
R-M1-8266 |
Chol-PEG2000-CRQRSRRRRRRSCQTHHHHH |
Chol-PEG2000-CRQRSRRRRRRSCQTHHHHH,Cholesterol-PEG2000-CRQRSRRRRRRSCQTHHHHH is a kind of peg derivative modified by heterobifunctional peptide sequence. |
price> |